Advancing Biotherapy Production with Continuous Manufacturing: RNA modalities will especially benefit from fuller adoption of continuous manufacturing platforms.

Detalles Bibliográficos
Publicado en:BioPharm International Vol. 38; no. 2; pp. 19 - 21
Autor principal: MIRASOL, FELIZA
Formato: pictorial Journal Article
Publicado: MJH Life Sciences Mar2025
Acceso en línea:Ver este registro en EBSCOhost